Autoinjectors Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

Autoinjectors Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

“DataM Intelligence”
The Autoinjectors Market is expected to grow at a CAGR of 19.2% during the forecast period 2022-2029.

Market Overview:

Autoinjectors Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 19.2% during the forecast period (2022-2029).

Autoinjectors are self-injectable gadgets that could supply drugs via subcutaneous or intramuscular routes. They preserve prefilled syringes or cartridges which are pushed with the aid of a spring gadget. The principal benefits of this tool are relaxed self-management, improved patient compliance, decreased anxiety, and dosage precision.

To Download free sample @

Market Dynamics

An increasing number of chronic diseases including cancer and diabetes drives the marketplace boom

The developing wide variety of persistent illnesses, consisting of cancer and diabetes, boosts the autoinjectors marketplace international. According to the World Health Organization (WHO), a globally agreed goal is to halt the advancement in diabetes and weight problems by 2025. Approximately 422 million people worldwide have diabetes, the superiority residing in low-and middle-income international locations, and 1.5Million deaths are immediately attributed to diabetes each yr.

The variety of cases and most of the people of diabetes have been step by step growing over the last few years. The growing variety of diabetes patients leads to increasing demand for autoinjectors to manage the disorder. The autoinjectors deliver the drug to diabetes sufferers. It gives smooth and secure management.

In September 2021, Owen Mumford Pharmaceutical Services introduced its new Aidaptus autoinjector platform. The new tool is a 2-step, spring-powered, single-use autoinjector designed to house 1 mL and 2.25 mL prefilled glass syringes within the equal base tool. Also, in May 2022, Halozyme Therapeutics, Inc. Obtained Antares Pharma, Inc.

The mixture of Halozyme and Antares will create a main drug transport and uniqueness product organization. The Antares enterprise includes a exceptional-in-class, differentiated, royalty revenue-generating autoinjector platform commercial enterprise that gives extensive licensing opportunities, and a industrial business, with 3 proprietary industrial products.

Market Segmentation:

By Type

  • Disposable Autoinjectors
  • Reusable Autoinjectors

By Technology

  • Manual Autoinjectors
  • Automated Autoinjectors

By Therapy

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Others

By End User

  • Home Care Setting
  • Hospitals

Competitive Landscape

The autoinjectors market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Kaléo, AbbVie, Amgen, Biogen Idec, AstraZeneca, Mylan, Pfizer, Teva Pharmaceuticals, Biogen, Eli Lilly, Merck & Co, Sandoz, Johnson &Johnson, YpsoMed, and Becton Dickinson and Company, among others. The major players are adopting several growth strategies such as Type launches, acquisitions, and collaborations, contributing to the global autoinjectors growth.

Trending Topics:

Sterile Injectable Market

Needle Free Injection Market

Injectable Drug Delivery Market

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States